questionsmedicales.fr
Composés chimiques organiques
Composés organiques du phosphore
Organophosphates
Organophosphates : Questions médicales fréquentes
Diagnostic
5
Intoxication
Acétylcholinestérase
Diagnostic
Tests de laboratoire
Cholinestérase
Exposition
Symptômes
Intoxication aiguë
Système nerveux
Évaluation
Symptômes
Acétylcholinestérase
Antécédents médicaux
Pesticides
Exposition
Symptômes
5
Symptômes neurologiques
Convulsions
Tremblements
Symptômes respiratoires
Bronchoconstriction
Toux
Symptômes gastro-intestinaux
Nausées
Vomissements
Signes vitaux
Fréquence cardiaque
Pression artérielle
Symptômes tardifs
Exposition
Intoxication
Prévention
5
Prévention
Équipements de protection
Pesticides
Agriculteurs
Protocoles de sécurité
Produits chimiques
Enfants
Vulnérabilité
Métabolisme
Stockage
Sécurité
Contenants hermétiques
Alternatives
Insecticides biologiques
Lutte intégrée
Traitements
5
Traitement
Atropine
Pralidoxime
Atropine
Récepteurs
Acétylcholine
Pralidoxime
Intoxication sévère
Acétylcholinestérase
Soins de soutien
Oxygénation
Monitoring
Antidotes
Atropine
Pralidoxime
Complications
5
Complications
Troubles neurologiques
Problèmes respiratoires
Séquelles
Intoxication
Neurologiques
Récidive
Exposition
Risques
Surveillance
Examens neurologiques
Tests fonctionnels
Qualité de vie
Complications
Activités quotidiennes
Facteurs de risque
5
Facteurs de risque
Travailleurs agricoles
Zones agricoles
Personnes âgées
Vulnérabilité
Fonction hépatique
Comportements à risque
Consignes de sécurité
Pesticides
Femmes enceintes
Exposition
Développement fœtal
Antécédents médicaux
Maladies respiratoires
Maladies neurologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Organophosphates : Questions médicales les plus fréquentes",
"headline": "Organophosphates : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Organophosphates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2026-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Organophosphates"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés organiques du phosphore",
"url": "https://questionsmedicales.fr/mesh/D009943",
"about": {
"@type": "MedicalCondition",
"name": "Composés organiques du phosphore",
"code": {
"@type": "MedicalCode",
"code": "D009943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "O-Phosphono-carbamate",
"alternateName": "Carbamyl Phosphate",
"url": "https://questionsmedicales.fr/mesh/D002221",
"about": {
"@type": "MedicalCondition",
"name": "O-Phosphono-carbamate",
"code": {
"@type": "MedicalCode",
"code": "D002221",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorfenvinphos",
"alternateName": "Chlorfenvinphos",
"url": "https://questionsmedicales.fr/mesh/D002709",
"about": {
"@type": "MedicalCondition",
"name": "Chlorfenvinphos",
"code": {
"@type": "MedicalCode",
"code": "D002709",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dichlorvos",
"alternateName": "Dichlorvos",
"url": "https://questionsmedicales.fr/mesh/D004006",
"about": {
"@type": "MedicalCondition",
"name": "Dichlorvos",
"code": {
"@type": "MedicalCode",
"code": "D004006",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.130"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mevinphos",
"alternateName": "Mevinphos",
"url": "https://questionsmedicales.fr/mesh/D008799",
"about": {
"@type": "MedicalCondition",
"name": "Mevinphos",
"code": {
"@type": "MedicalCode",
"code": "D008799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.501"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Monocrotophos",
"alternateName": "Monocrotophos",
"url": "https://questionsmedicales.fr/mesh/D008999",
"about": {
"@type": "MedicalCondition",
"name": "Monocrotophos",
"code": {
"@type": "MedicalCode",
"code": "D008999",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Naled",
"alternateName": "Naled",
"url": "https://questionsmedicales.fr/mesh/D009267",
"about": {
"@type": "MedicalCondition",
"name": "Naled",
"code": {
"@type": "MedicalCode",
"code": "D009267",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Paraoxon",
"alternateName": "Paraoxon",
"url": "https://questionsmedicales.fr/mesh/D010261",
"about": {
"@type": "MedicalCondition",
"name": "Paraoxon",
"code": {
"@type": "MedicalCode",
"code": "D010261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phosphamidon",
"alternateName": "Phosphamidon",
"url": "https://questionsmedicales.fr/mesh/D010707",
"about": {
"@type": "MedicalCondition",
"name": "Phosphamidon",
"code": {
"@type": "MedicalCode",
"code": "D010707",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Polyisoprényl-phosphates",
"alternateName": "Polyisoprenyl Phosphates",
"url": "https://questionsmedicales.fr/mesh/D011106",
"about": {
"@type": "MedicalCondition",
"name": "Polyisoprényl-phosphates",
"code": {
"@type": "MedicalCode",
"code": "D011106",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tétrachlorvinphos",
"alternateName": "Tetrachlorvinphos",
"url": "https://questionsmedicales.fr/mesh/D013751",
"about": {
"@type": "MedicalCondition",
"name": "Tétrachlorvinphos",
"code": {
"@type": "MedicalCode",
"code": "D013751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tritolylphosphates",
"alternateName": "Tritolyl Phosphates",
"url": "https://questionsmedicales.fr/mesh/D014317",
"about": {
"@type": "MedicalCondition",
"name": "Tritolylphosphates",
"code": {
"@type": "MedicalCode",
"code": "D014317",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.400.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Organophosphates",
"alternateName": "Organophosphates",
"code": {
"@type": "MedicalCode",
"code": "D010755",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Bi-Xian Mai",
"url": "https://questionsmedicales.fr/author/Bi-Xian%20Mai",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Organic Geochemistry and Guangdong Key Laboratory of Environmental Protection and Resources Utilization, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, Guangzhou, 510640, China."
}
},
{
"@type": "Person",
"name": "Nannan Zhao",
"url": "https://questionsmedicales.fr/author/Nannan%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China."
}
},
{
"@type": "Person",
"name": "Jie Fu",
"url": "https://questionsmedicales.fr/author/Jie%20Fu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China."
}
},
{
"@type": "Person",
"name": "Yifei Liu",
"url": "https://questionsmedicales.fr/author/Yifei%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China."
}
},
{
"@type": "Person",
"name": "Peilong Wang",
"url": "https://questionsmedicales.fr/author/Peilong%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Peroxide-Mediated Release of Organophosphates from Boron-Containing Phosphotriesters: A New Class of Organophosphate Prodrugs.",
"datePublished": "2023-07-18",
"url": "https://questionsmedicales.fr/article/37463277",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.orglett.3c02036"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides.",
"datePublished": "2023-08-31",
"url": "https://questionsmedicales.fr/article/37650603",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.chemrestox.3c00188"
}
},
{
"@type": "ScholarlyArticle",
"name": "Maternal exposure to organophosphate flame retardants and neonatal anthropometric measures.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37516025",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijheh.2023.114216"
}
},
{
"@type": "ScholarlyArticle",
"name": "Residue levels of organophosphate pesticides and dialkylphosphates in agricultural products in Japan.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37394165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.envres.2023.116518"
}
},
{
"@type": "ScholarlyArticle",
"name": "Organophosphate esters concentrations in human serum and their associations with Sjögren syndrome.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37263569",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.envpol.2023.121941"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés organiques du phosphore",
"item": "https://questionsmedicales.fr/mesh/D009943"
},
{
"@type": "ListItem",
"position": 4,
"name": "Organophosphates",
"item": "https://questionsmedicales.fr/mesh/D010755"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Organophosphates - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Organophosphates",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Organophosphates",
"description": "Comment diagnostiquer une intoxication aux organophosphates ?\nQuels tests sont utilisés pour confirmer l'exposition ?\nQuels symptômes indiquent une intoxication aiguë ?\nComment évaluer la gravité de l'intoxication ?\nQuels antécédents médicaux sont pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D010755#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Organophosphates",
"description": "Quels sont les symptômes neurologiques des organophosphates ?\nComment se manifestent les symptômes respiratoires ?\nY a-t-il des symptômes gastro-intestinaux ?\nQuels signes vitaux sont affectés ?\nLes symptômes peuvent-ils apparaître tardivement ?",
"url": "https://questionsmedicales.fr/mesh/D010755#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Organophosphates",
"description": "Comment prévenir l'exposition aux organophosphates ?\nQuelles sont les recommandations pour les agriculteurs ?\nLes enfants sont-ils plus à risque ?\nComment stocker les organophosphates en toute sécurité ?\nQuelles sont les alternatives aux organophosphates ?",
"url": "https://questionsmedicales.fr/mesh/D010755#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Organophosphates",
"description": "Quel est le traitement principal de l'intoxication ?\nComment l'atropine agit-elle contre l'intoxication ?\nQuand utiliser le pralidoxime ?\nQuels soins de soutien sont nécessaires ?\nY a-t-il des antidotes spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D010755#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Organophosphates",
"description": "Quelles sont les complications à long terme ?\nL'intoxication peut-elle entraîner des séquelles ?\nQuels sont les risques de récidive ?\nComment les complications sont-elles surveillées ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D010755#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Organophosphates",
"description": "Qui est le plus à risque d'intoxication ?\nLes personnes âgées sont-elles plus vulnérables ?\nQuels comportements augmentent le risque ?\nLes femmes enceintes sont-elles à risque ?\nLes personnes avec des antécédents médicaux sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D010755#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux organophosphates ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour mesurer l'activité de l'acétylcholinestérase."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de cholinestérase dans le sang et des analyses d'urine peuvent confirmer l'exposition."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aiguë ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, des convulsions et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité de l'intoxication ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par l'intensité des symptômes et les niveaux d'acétylcholinestérase dans le sang."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'exposition professionnelle ou domestique aux pesticides sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes neurologiques des organophosphates ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes neurologiques incluent des tremblements, des convulsions et une confusion mentale."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes respiratoires peuvent inclure une respiration difficile, une toux et une bronchoconstriction."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes gastro-intestinaux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nausées, vomissements et diarrhées peuvent survenir lors d'une intoxication."
}
},
{
"@type": "Question",
"name": "Quels signes vitaux sont affectés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fréquence cardiaque et la pression artérielle peuvent être altérées, avec des variations possibles."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître tardivement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains symptômes peuvent apparaître plusieurs heures après l'exposition initiale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux organophosphates ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle lors de l'application de pesticides."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les agriculteurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les agriculteurs doivent suivre les protocoles de sécurité et les instructions d'utilisation des produits."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus vulnérables aux effets des organophosphates en raison de leur taille et métabolisme."
}
},
{
"@type": "Question",
"name": "Comment stocker les organophosphates en toute sécurité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les organophosphates doivent être stockés dans des contenants hermétiques, hors de portée des enfants."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives aux organophosphates ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des alternatives incluent des insecticides biologiques et des méthodes de lutte intégrée."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut l'administration d'atropine et de pralidoxime pour contrer les effets."
}
},
{
"@type": "Question",
"name": "Comment l'atropine agit-elle contre l'intoxication ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'atropine bloque les récepteurs de l'acétylcholine, réduisant ainsi les effets toxiques."
}
},
{
"@type": "Question",
"name": "Quand utiliser le pralidoxime ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le pralidoxime est utilisé en cas d'intoxication sévère pour régénérer l'acétylcholinestérase."
}
},
{
"@type": "Question",
"name": "Quels soins de soutien sont nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de soutien incluent l'oxygénation, la ventilation et le monitoring des signes vitaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des antidotes spécifiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'atropine et le pralidoxime sont les antidotes spécifiques pour les organophosphates."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des troubles neurologiques chroniques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "L'intoxication peut-elle entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles neurologiques peuvent persister longtemps après l'exposition initiale."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de récidive ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant déjà été exposées peuvent être à risque de récidive lors d'une nouvelle exposition."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles surveillées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont surveillées par des examens neurologiques réguliers et des tests fonctionnels."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie et les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'intoxication ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs agricoles et les personnes vivant près des zones agricoles sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus vulnérables en raison de la diminution de la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le non-respect des consignes de sécurité lors de l'utilisation de pesticides augmente le risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition pendant la grossesse peut affecter le développement du fœtus."
}
},
{
"@type": "Question",
"name": "Les personnes avec des antécédents médicaux sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents de maladies respiratoires ou neurologiques sont plus à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/04/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
State Key Laboratory of Organic Geochemistry and Guangdong Key Laboratory of Environmental Protection and Resources Utilization, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, Guangzhou, 510640, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Institute of Quality Standard and Testing Technology for Agro-Products, The Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Industrial Ecology and Environmental Engineering (Ministry of Education), School of Environmental Science and Technology, Dalian University of Technology, Dalian 116024, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Department of Environmental Chemistry, Jordi Girona, 18, 08034 Barcelona, Catalonia, Spain.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Department of Environmental Chemistry, Jordi Girona, 18, 08034 Barcelona, Catalonia, Spain. Electronic address: joan.grimalt@idaea.csic.es.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Department of Earth Sciences, University of Toronto, 22 Ursula Franklin Street, Toronto, Ontario M5S 3B1, Canada.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian 116024, China. Electronic address: wangyandut@dlut.edu.cn.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian 116024, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
School of Environment, Guangdong Provincial Key Laboratory of Chemical Pollution and Environmental Safety & MOE Key Laboratory of Theoretical Chemistry of Environment, South China Normal University, Guangzhou, 510006, China.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
School of Environment, Guangdong Provincial Key Laboratory of Chemical Pollution and Environmental Safety & MOE Key Laboratory of Theoretical Chemistry of Environment, South China Normal University, Guangzhou, 510006, China. Electronic address: shejun.chen@m.scnu.edu.cn.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Fish Ecophysiology, Department of Fisheries Management, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Fish Ecophysiology, Department of Fisheries Management, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Academic Department of Chemistry and Biology, Universidade Tecnológica Federal do Paraná, 81280-340, Curitiba-PR, Brazil.
Department of Chemistry, Universidade Federal do Paraná, CP 19081, CEP 81531-990, Curitiba-PR, Brazil.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Universidade Federal do Paraná, CP 19081, CEP 81531-990, Curitiba-PR, Brazil.
Publications dans "Organophosphates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Universidade Federal do Paraná, CP 19081, CEP 81531-990, Curitiba-PR, Brazil.
Publications dans "Organophosphates" :
Phosphate mono- and diesters can be liberated efficiently from boryl allyloxy (BAO) and related phosphotriesters by H...
CYP2C19 is an important enzyme for organophosphate pesticide (OPP) metabolism. Because the OPPs can be both substrates and inhibitors of CYP2C19, we screened 45 OPPs for their ability to inhibit the a...
Organophosphate flame retardants (OPFRs) are widely used as flame retardants and plasticizers. Laboratory evidence has suggested that maternal OPFR exposure may adversely affect fetal growth, but the ...
To investigate the association of maternal OPFR exposure with neonatal anthropometric measures....
This study included 354 mother-newborn pairs from the Laizhou Wan Birth Cohort (LWBC), China. Ten OPFR metabolites were measured in maternal urine samples collected before delivery. Neonatal anthropom...
The detection rates of BCEP, DPHP, BCIPP, BDCIPP, BBOEP, DnBP and DiBP were above 60%, with median concentrations ranging from 0.14 to 3.60 μg/g creatinine. Most OPFR metabolites (i.e., BCIPP, BDCIPP,...
Maternal OPFR exposure was negatively associated with offspring WAZ, BMIZ, and HCZ, and males seemed to be more vulnerable to the developmental toxicity of certain OPFRs....
High urinary levels of dialkylphosphates (DAPs), which are common structures of organophosphate pesticides (OPs), have been associated with several adverse health outcomes in human biomonitoring studi...
Organophosphate esters (OPEs) are widely used as flame retardants and plasticizers due to their excellent properties. The interference of OPEs on immune function has been proven, but the epidemiologic...
Organophosphate flame retardants (OPFRs) are an important group of pollutants associated with endocrine disorders, cancer, and nephrotoxicity. However, temporal trends in OPFR metabolite concentration...
To examine changes in urinary concentrations of OPFR metabolites among US children, youths, and adults from 2011 to 2020, and to evaluate whether sociodemographic factors were associated with variatio...
This population-based cross-sectional study used data from 4 US National Health and Nutrition Examination Survey (NHANES) cycles (2011-2012, 2013-2014, 2015-2016, and 2017-2020 [to March 2020 before t...
Calendar year and key sociodemographic subgroups (age, race and ethnicity, sex, educational attainment, and poverty-to-income ratio)....
The main outcome was urinary concentrations of OPFR metabolites among children, youths, and adults. Survey-weighted linear regression models were applied to estimate trends....
The study population of 10 549 NHANES participants included 3154 children and youths (mean [SE] age, 12.5 [0.1] years; 51.2% were male) and 7395 adults (mean [SE] age, 47.8 [0.4] years; 52.0% were wom...
This study identified variations in temporal trends in urinary concentrations of OPFR metabolites among the US population from 2011 to 2020. In addition, substantial disparities in exposure levels per...
Recent studies have identified the ability of plants to uptake and translocate organophosphate esters (OPEs) within cells. In response to the increasing interest in OPEs and their occurrence in paddy ...
Owing to their potential to cause serious adverse health effects, significant efforts have been made to develop antidotes for organophosphate (OP) anticholinesterases, such as nerve agents. To be opti...
Although firefighters are at an increased risk of occupational exposure to chemicals, such as flame retardants, research on the exposure of Korean firefighters to organophosphate esters (OPEs)-a group...
Organophosphate esters (OPEs) have been broadly used in various industrial and consumer products, resulting in global distribution and human exposure. Gestational exposure to OPEs may adversely affect...